DoD Breast Cancer Breakthrough Award Level 3
Department of Defense
Description
This grant opportunity supports innovative research with the potential for major breakthroughs in breast cancer. Applicants must address one of the Breast Cancer Research Program's key challenges for FY25, unless an exception is justified. The current announcement focuses on Breakthrough Award Level 3, which supports various stages of research leading to clinical application. Small-scale clinical trials are allowed but not mandatory. Research teams must include at least two breast cancer con…
Summary: Supports promising research that has high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) overarching challenges, unless adequate justification f…
Source
Grant ID
HT942525BCRPBTA3
Agency
Department of Defense
Subcategory/Subagency
Dept. of the Army -- USAMRAA
Key Dates
Solicitation Posted
April 22, 2025
Application Response Due
September 10, 2025
Solicitation Closed
October 10, 2025
Eligibility
The following categories of applicants are invited to apply:
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Awards & Funding
Total Funding
$25.2M
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- DoD Breast Cancer, Clinical Research Extension Award
Department of Defense
- DoD Breast Cancer, Breakthrough Award Levels 1 and 2
Department of Defense
- DOD Peer Reviewed Cancer, Impact Award
Department of Defense
- DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option
Department of Defense
- DoD Prostate Cancer, Idea Development Award
Department of Defense